Cargando…

The feasibility of implementing an English language version of GLA:D Back

BACKGROUND: Evidenced-based clinical guidelines for the treatment of low back pain (LBP) consistently suggest educating patients about their back pain, its natural course, and providing advice to keep active and continue working. Despite this evidence, clinicians routinely do not follow these recomm...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemieux, J., Kawchuk, G., Kongsted, A., Hartvigsen, J., Abdollah, V., Jones, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849100/
https://www.ncbi.nlm.nih.gov/pubmed/33522956
http://dx.doi.org/10.1186/s40814-020-00758-z
_version_ 1783645248405110784
author Lemieux, J.
Kawchuk, G.
Kongsted, A.
Hartvigsen, J.
Abdollah, V.
Jones, A.
author_facet Lemieux, J.
Kawchuk, G.
Kongsted, A.
Hartvigsen, J.
Abdollah, V.
Jones, A.
author_sort Lemieux, J.
collection PubMed
description BACKGROUND: Evidenced-based clinical guidelines for the treatment of low back pain (LBP) consistently suggest educating patients about their back pain, its natural course, and providing advice to keep active and continue working. Despite this evidence, clinicians routinely do not follow these recommendations resulting in ineffective and fragmented care. GLA:D® Back, a standardized care package, was originally developed in Denmark to assist clinicians in implementing evidence-based care. This study will evaluate the feasibility of implementing the English version of the Danish GLA:D® Back program in Alberta, Canada. METHODS: Thirty-five clinicians from nineteen clinics in Alberta, Canada, participated. Feasibility of program implementation, our primary objective, was evaluated within 3 months. Feasibility success was defined as 50% clinician/clinic adoption in addition to 66–88 enrolled participants registered in the database. Our secondary objectives included collecting data pertaining to clinician confidence, attitudes and behaviour of treating patients, perceived barriers and facilitators of program in addition to collecting patient-data regarding pain, function, general health and self-efficacy. RESULTS: The majority of the clinics (15/19, 79%) offered GLA:D® Back to their patients within the study period. Of the participating clinicians, GLA:D® Back was delivered by (25/35, 71%) of clinicians. In total, 78 patients were enrolled in the program and (69/78, 88%) participants attended the final assessment. Secondarily, clinicians demonstrated a biomedical and behavioural orientation along with high confidence when treating LBP patients while patient outcomes trended toward improvement. CONCLUSION: The English translation of the Danish GLA:D Back program was feasible for Albertan clinicians to implement into practice in both urban and rural settings.
format Online
Article
Text
id pubmed-7849100
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78491002021-02-03 The feasibility of implementing an English language version of GLA:D Back Lemieux, J. Kawchuk, G. Kongsted, A. Hartvigsen, J. Abdollah, V. Jones, A. Pilot Feasibility Stud Research BACKGROUND: Evidenced-based clinical guidelines for the treatment of low back pain (LBP) consistently suggest educating patients about their back pain, its natural course, and providing advice to keep active and continue working. Despite this evidence, clinicians routinely do not follow these recommendations resulting in ineffective and fragmented care. GLA:D® Back, a standardized care package, was originally developed in Denmark to assist clinicians in implementing evidence-based care. This study will evaluate the feasibility of implementing the English version of the Danish GLA:D® Back program in Alberta, Canada. METHODS: Thirty-five clinicians from nineteen clinics in Alberta, Canada, participated. Feasibility of program implementation, our primary objective, was evaluated within 3 months. Feasibility success was defined as 50% clinician/clinic adoption in addition to 66–88 enrolled participants registered in the database. Our secondary objectives included collecting data pertaining to clinician confidence, attitudes and behaviour of treating patients, perceived barriers and facilitators of program in addition to collecting patient-data regarding pain, function, general health and self-efficacy. RESULTS: The majority of the clinics (15/19, 79%) offered GLA:D® Back to their patients within the study period. Of the participating clinicians, GLA:D® Back was delivered by (25/35, 71%) of clinicians. In total, 78 patients were enrolled in the program and (69/78, 88%) participants attended the final assessment. Secondarily, clinicians demonstrated a biomedical and behavioural orientation along with high confidence when treating LBP patients while patient outcomes trended toward improvement. CONCLUSION: The English translation of the Danish GLA:D Back program was feasible for Albertan clinicians to implement into practice in both urban and rural settings. BioMed Central 2021-02-01 /pmc/articles/PMC7849100/ /pubmed/33522956 http://dx.doi.org/10.1186/s40814-020-00758-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lemieux, J.
Kawchuk, G.
Kongsted, A.
Hartvigsen, J.
Abdollah, V.
Jones, A.
The feasibility of implementing an English language version of GLA:D Back
title The feasibility of implementing an English language version of GLA:D Back
title_full The feasibility of implementing an English language version of GLA:D Back
title_fullStr The feasibility of implementing an English language version of GLA:D Back
title_full_unstemmed The feasibility of implementing an English language version of GLA:D Back
title_short The feasibility of implementing an English language version of GLA:D Back
title_sort feasibility of implementing an english language version of gla:d back
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849100/
https://www.ncbi.nlm.nih.gov/pubmed/33522956
http://dx.doi.org/10.1186/s40814-020-00758-z
work_keys_str_mv AT lemieuxj thefeasibilityofimplementinganenglishlanguageversionofgladback
AT kawchukg thefeasibilityofimplementinganenglishlanguageversionofgladback
AT kongsteda thefeasibilityofimplementinganenglishlanguageversionofgladback
AT hartvigsenj thefeasibilityofimplementinganenglishlanguageversionofgladback
AT abdollahv thefeasibilityofimplementinganenglishlanguageversionofgladback
AT jonesa thefeasibilityofimplementinganenglishlanguageversionofgladback
AT lemieuxj feasibilityofimplementinganenglishlanguageversionofgladback
AT kawchukg feasibilityofimplementinganenglishlanguageversionofgladback
AT kongsteda feasibilityofimplementinganenglishlanguageversionofgladback
AT hartvigsenj feasibilityofimplementinganenglishlanguageversionofgladback
AT abdollahv feasibilityofimplementinganenglishlanguageversionofgladback
AT jonesa feasibilityofimplementinganenglishlanguageversionofgladback